| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 69.4 | 56.8 | 38.3 |
| Other income | 1.2 | 2.9 | 0.7 |
| Total income | 70.6 | 59.7 | 38.9 |
| Profit before exceptional items & tax | 3.3 | 8.3 | 2.4 |
| Profit before tax | 3.3 | 8.3 | 2.4 |
| Net profit | 2.5 | 5.9 | 1.8 |
| Operating margin | 4.7% | 13.9% | 6.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +38.90% |
|---|---|
| Net profit, quarter on quarter | -57.60% |
| Revenue, year on year | +81.20% |
| Operating profit, year on year | +23.50% |
| Operating profit, quarter on quarter | -61.10% |
BSE results filing, NSE: MEDICO. Figures extracted from the filing.
Medico Remedies Ltd: key numbers
- Share price
- ₹22.49
- Market cap
- ₹186.6 Cr
- Revenue (annual)
- ₹206.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 13.5×Sector 47.4×
- Promoter holding
- 61.38%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Remedies Ltd
All →Medico Remedies Annual General Meeting
Medico Remedies Ltd held its 32nd Annual General Meeting on September 22, 2026, transacting ordinary and special business, including director re-appointments and remuneration revisions.
Medico Remedies Annual Report
Medico Remedies Ltd has submitted its Annual Report for the financial year 2025-26 and the Notice of its 32nd Annual General Meeting.
Medico Remedies Annual General Meeting
Medico Remedies Limited has issued a notice for its 32nd Annual General Meeting scheduled for September 22, 2026. The meeting agenda includes financial statements and director re-appointments.
Medico Remedies Annual General Meeting
Medico Remedies Limited announced its 32nd Annual General Meeting scheduled for September 22, 2026. The meeting will seek shareholder approval for financial statements and various director appointments.
- Value
- ₹0.10 Cr
Medico Remedies Price Movement Clarification
Medico Remedies Ltd clarified that recent share price and volume movements are purely market-driven, stating no undisclosed information exists under SEBI regulations.
Medico Remedies Management Change
Medico Remedies Limited has re-appointed Mr. Rishit Mehta and Mr. Haresh Mehta as Executive Directors for a three-year term effective September 18, 2026.